References
- 1NystromL, RutqvistLE, WallS, LindgrenA, LindqvistM, RydenS, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341(8851):973–978. doi:10.1016/0140-6736(93)91067-V8096941
- 2StolbergHO, NormanG, TropI Randomized controlled trials. AJR 2004;183(6):1539–1544. doi: 10.2214/ajr.183.6.0183153915547188
- 3PfeiferMP, SnodgrassGL The continued use of retracted, invalid scientific literature. JAMA 1990;263(10):1420–1423. doi:10.1001/jama.1990.034401001400202406475
- 4OlkinI Meta-analysis: reconciling the results of independent studies. Stat Med 1995;14(5–7):457–472. doi:10.1002/sim.47801405077792440
- 5Every-PalmerS, HowickJ How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract 2014;20(6):908–914. doi: 10.1111/jep.1214724819404
- 6MoherD, PhamB, JonesA, CookDJ, JadadAR, MoherM, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352(9128):609–613. doi: 10.1016/s0140-6736(98)01085-x9746022
- 7SchulzKF, ChalmersI, HayesRJ, AltmanDG Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408–412. doi:10.1001/jama.1995.035202900600307823387
- 8Huwiler-MuntenerK, JuniP, JunkerC, EggerM Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002;287(21):2801–2804. doi:10.1001/jama.287.21.280112038917
- 9JuniP, AltmanDG, EggerM Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42–46. doi: 10.1136/bmj.323.7303.4211440947
- 10LiberatiA, HimelHN, ChalmersTC A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 1986;4(6):942–951. doi: 10.1200/JCO.1986.4.6.9423711962
- 11TurnerL, ShamseerL, AltmanDG, WeeksL, PetersJ, KoberT, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012;11:Mr000030. doi: 10.1002/14651858.MR000030.pub223152285
- 12ChanAW, AltmanDG Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005;365(9465):1159–1162. doi: 10.1016/s0140-6736(05)71879-115794971
- 13SchulzKF, AltmanDG, MoherD CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010;8:18. doi: 10.1136/bmj.c33220334633
- 14ZiogasDC, ZintzarasE Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ann Epidemiol 2009;19(7):494–500. doi: 10.1016/j.annepidem.2009.03.01819523596
- 15LaiTY, WongVW, LamRF, ChengAC, LamDS, LeungGM Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol 2007;14(6):390–398. doi: 10.1080/0928658070134439918161613
- 16AghaR, CooperD, MuirG The reporting quality of randomised controlled trials in surgery: a systematic review. Int J Surg 2007;5(6):413–422. doi: 10.1016/j.ijsu.2007.06.00218029237
- 17HillCL, BuchbinderR, OsborneR Quality of reporting of randomized clinical trials in abstracts of the 2005 annual meeting of the American College of Rheumatology. J Rheumatol 2007;34(12):2476–2480.17985398
- 18FarrokhyarF, ChuR, WhitlockR, ThabaneL A systematic review of the quality of publications reporting coronary artery bypass grafting trials. Can J Surg 2007;50(4):266–277.17897515
- 19MillsE, LokeYK, WuP, MontoriVM, PerriD, MoherD, et al. Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol 2004;58(1):61–65. doi: 10.1111/j.1365-2125.2004.2092.x15206994
- 20PartsinevelouA, ZintzarasE Quality of reporting of randomized controlled trials in polycystic ovary syndrome. Trials 2009;10:106. doi: 10.1186/1745-6215-10-10619930576
- 21RikosD, DardiotisE, TsivgoulisG, ZintzarasE, HadjigeorgiouGM Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement. Mult Scler Relat Disord 2016;9:135–139. doi: 10.1016/j.msard.2016.07.013
- 22AllenRP, BharmalM, CallowayM Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord 2011;26(1):114–120. doi: 10.1002/mds.2343021322022
- 23AllenRP, PicchiettiDL, Garcia-BorregueroD, OndoWG, WaltersAS, WinkelmanJW, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 2014;15(8):860–873. doi: 10.1016/j.sleep.2014.03.02525023924
- 24AllenRP, StillmanP, MyersAJ Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics. Sleep Med 2010;11(1):31–37. doi: 10.1016/j.sleep.2009.03.00719464949
- 25StefanidisI, VainasA, DardiotisE, GiannakiCD, GourliP, PapadopoulouD, et al. Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. Sleep Med 2013;14(12):1381–1386. doi: 10.1016/j.sleep.2013.05.02224210601
- 26StefanidisI, VainasA, GiannakiCD, DardiotisE, SpanoulisA, SounidakiM, et al. Restless legs syndrome does not affect 3-year mortality in hemodialysis patients. Sleep Med 2015;16(9):1131–1138. doi: 10.1016/j.sleep.2015.04.02326298790
- 27HadjigeorgiouGM, StefanidisI, DardiotisE, AggellakisK, SakkasGK, XiromerisiouG, et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol 2007;14(11):1275–1280. doi: 10.1111/j.1468-1331.2007.01966.x17956448
- 28SchormairB, PlagJ, KaffeM, GrossN, CzamaraD, SamtlebenW, et al. MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease. J Med Genet 2011;48(7):462–466. doi: 10.1136/jmg.2010.08785821572129
- 29NolanSJ, HambletonI, DwanK The use and reporting of the cross-over study design in clinical trials and systematic reviews: a systematic assessment. PLoS One 2016;11(7):e0159014. doi: 10.1371/journal.pone.015901427409076
- 30BeggC, ChoM, EastwoodS, HortonR, MoherD, OlkinI, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276(8):637–639. doi:10.1001/jama.1996.035400800590308773637
- 31KoberT, TrelleS, EngertA Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. J Natl Canc Inst 2006;98(9):620–625. doi: 10.1093/jnci/djj160
- 32PildalJ, HrobjartssonA, JorgensenKJ, HildenJ, AltmanDG, GotzschePC Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007;36(4):847–857. doi: 10.1093/ije/dym08717517809
- 332015 Journal Citation Reports®: (Thomson Reuters, 2016).
- 34WoodL, EggerM, GluudLL, SchulzKF, JuniP, AltmanDG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336(7644):601–605. doi: 10.1136/bmj.39465.451748.AD18316340